Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency
- PMID: 27392462
- DOI: 10.1016/j.clim.2016.07.001
Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency
Abstract
Common variable immunodeficiency (CVID) is the most common symptomatic primary antibody deficiency and is associated with recurrent infections and chronic inflammatory diseases. We evaluated the ability of Toll-like receptor (TLR) ligands to induce secretion of chemokines, cytokines and type I interferons by peripheral blood mononuclear cells (PBMCs) from CVID patients. High levels of CXCL10, CCL2, CXCL9, CCL5, CXCL8, and IL-6 were detected in sera of CVID patients compared with healthy controls. Increased chemokine levels were observed in unstimulated PBMCs, but after stimulation with TLR2 and TLR4 agonists, equivalent chemokine and pro-inflammatory cytokine secretion, as in healthy controls, was observed, whereas TLR4 agonist induced a decreased secretion of CCL2 and CXCL8 and increased secretion of TNF. Decreased IFN-α secretion induced by TLR7/TLR8 activation was observed in CVID, which was recovered with TLR9 signaling. Our findings revealed that TLR9 activation has an adjuvant effect on the altered type I response in CVID.
Keywords: Chemokines; Common variable immunodeficiency; Cytokines; Toll-like receptor agonists.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.Br J Dermatol. 2015 Jan;172(1):48-55. doi: 10.1111/bjd.13214. Epub 2014 Nov 20. Br J Dermatol. 2015. PMID: 24976336
-
Toll-like receptor 7 and 9 defects in common variable immunodeficiency.J Allergy Clin Immunol. 2009 Aug;124(2):349-56, 356.e1-3. doi: 10.1016/j.jaci.2009.05.019. Epub 2009 Jul 9. J Allergy Clin Immunol. 2009. PMID: 19592080 Free PMC article.
-
TLR activation pathways in HIV-1-exposed seronegative individuals.J Immunol. 2010 Mar 1;184(5):2710-7. doi: 10.4049/jimmunol.0902463. Epub 2010 Feb 1. J Immunol. 2010. PMID: 20124101
-
The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.Expert Rev Clin Immunol. 2016;12(2):195-207. doi: 10.1586/1744666X.2016.1114885. Epub 2015 Dec 14. Expert Rev Clin Immunol. 2016. PMID: 26654573 Review.
-
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma.Curr Opin Oncol. 2014 Mar;26(2):237-44. doi: 10.1097/CCO.0000000000000048. Curr Opin Oncol. 2014. PMID: 24441505 Review.
Cited by
-
Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency.J Clin Immunol. 2022 Aug;42(6):1254-1269. doi: 10.1007/s10875-022-01291-9. Epub 2022 May 19. J Clin Immunol. 2022. PMID: 35589883 Free PMC article.
-
High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study.J Clin Immunol. 2024 Feb 6;44(2):59. doi: 10.1007/s10875-024-01656-2. J Clin Immunol. 2024. PMID: 38319477 Free PMC article.
-
Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications.J Allergy Clin Immunol. 2022 Jan;149(1):315-326.e9. doi: 10.1016/j.jaci.2021.06.008. Epub 2021 Jun 17. J Allergy Clin Immunol. 2022. PMID: 34146579 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous